Abstract:Drug transporters and drug metabolism enzymes govern drug absorption, distribution, metabolism and elimination. Many literature works presenting important aspects related to stereochemistry of drug metabolism are available. However, there is very little literature on stereoselectivity of chiral drug transport and enantiomer–transporter interaction. In recent years, the experimental research within this field showed good momentum. Herein, an up-to-date review on this topic was presented. Breast Cancer Resistance Protein (BCRP), Multidrug Resistance Proteins (MRP), P-glycoprotein (P-gp), Organic Anion Transporters (OATs), Organic Anion Transporting Polypeptides (OATPs), Organic Cation Transporters (OCTs), Peptide Transport Proteins (PepTs), Human Proton-Coupled Folate Transporter (PCFT) and Multidrug and Toxic Extrusion Proteins (MATEs), have been reported to exhibit either positive or negative enantio-selective substrate recognition. The approaches utilized to study chirality in enantiomer–transporter interaction include inhibition experiments of specific transporters in cell models (e.g. Caco-2 cells), transport study using drug resistance cell lines or transgenic cell lines expressing transporters in wild type or variant, the use of transporter knockout mice, pharmacokinetics association of single nucleotide polymorphism in transporters, pharmacokinetic interaction study of racemate in the presence of specific transporter inhibitor or inducer, molecule cellular membrane affinity chromatography and pharmacophore modeling. Enantiomer–enantiomer interactions exist in chiral transport. The strength and/or enantiomeric preference of stereoselectivity may be species or tissue-specific, concentration-dependent and transporter family member-dependent. Modulation of specific drug transporter by pure enantiomers might exhibit opposite stereoselectivity. Further studies with integrated approaches will open up new horizons in stereochemistry of pharmacokinetics.

Stereoselectivity in pharmacokinetics of chiral drugs

Chiral pharmaceuticals: A review on their environmental occurrence and fate processes

Advance in Search for Stereoselectivity in Pharmacokinetics and Its Effect Factors of Chiral Drugs

Stereoselectivity of Chiral Drug Transport: a Focus on Enantiomer–transporter Interaction

Stereoselective Pharmacokinetics and Chiral Inversions of Some Chiral Hydroxy Group Drugs

Stereoselective Binding of Chiral Drugs to Plasma Proteins

Stereoselective Metabolic and Pharmacokinetic Analysis of the Chiral Active Components from Herbal Medicines

Interactions Between the Enantiomers of Chiral Drugs on the Pharmacodynamics and Pharmacokinetics

Significance and Challenges of Stereoselectivity Assessing Methods in Drug Metabolism.

Enantioselectivity in Biotransformation and Bioaccumulation Processes of Typical Chiral Contaminants

Enantioselectivity in Drug Pharmacokinetics and Toxicity: Pharmacological Relevance and Analytical Methods

Analysis of stereoisomers of chiral drug by mass spectrometry

Chiral Recognition for Chromatography and Membrane-Based Separations: Recent Developments and Future Prospects

Chiral Selectivity in the Environmental Fate of Pyrethroids

Phytotoxicity And Environmental Fate Of Chiral Herbicides

Enantioselective Toxicity of Chiral Pesticides in Aquatic Systems

Mechanisms for Translating Chiral Enantiomers Separation Research into Macroscopic Visualization

Analysis of Stereoisomers of Chiral Drug by Mass Spectrometry.

Research Progress on Chiral Supramolecular Sensors for Enantiomer Detection

Chiral Switch: Between Therapeutical Benefit and Marketing Strategy

Molecular Docking of Chiral Drug Enantiomers With Different Bioactivities